Researchers have detected elevated endogenous tau in the cerebrospinal fluid of Aβ mouse models.
Leaders protest recent decision to deny Medicare beneficiaries coverage of amyloid scans.
At AAIC 2013, researchers present the latest genetic risk factors for Alzheimer's disease.
Researchers at AAIC 2013 report that an individual’s subjective sense of worsening memory could be an important predictor of cognitive impairment and dementia.
Update on compounds in Phase 2 and 3 trials from the Alzheimer's Association International Conference
Speakers at Alzheimer’s conference reviewed planned Phase 1 and prevention trials and preclinical studies.
Removing a key component of the innate immune system worsens amyloid deposition but improves memory in mice that model Alzheimer's pathology.
Hunting for rare mutations that cause dementia, researchers have spotted, but not yet snagged, some tantalizing candidates.
Studies reported at AAIC demonstrate that biomarkers help predict who will develop cognitive impairment and dementia.
AD but no Amyloidβ? Researchers at AAIC 2013 theorized on the pathology underlying this form of dementia.
The proportion of seniors with dementia in England appears to be on the decline, new research suggests.
Protein strains may underlie different tauopathies, according to researchers presented at this year's AAIC meeting in Boston.
Tau ligands for PET scans were among the hot topics at the Alzheimer’s Association International Conference in Boston.
Is transfer of tau from one neuron to the next a normal activity, hijacked by pathogenic protein in the case of tauopathies?